DECLIC Patient Education Program : Assessment Through a Population Health Intervention Research Approach (LE DECLIC EPRI)

Last updated: September 13, 2024
Sponsor: Institut Curie
Overall Status: Completed

Phase

N/A

Condition

Cancer Pain

Pain

Chronic Pain

Treatment

standrad group

Experimental group

Clinical Study ID

NCT04634097
IC 2019-06
  • Ages > 18
  • All Genders

Study Summary

Cancer pain is a frequent symptom, reported by 20 to 70% of patients in any stage of the cancer disease : 60 to 70% in the advanced stage of the disease and 20 to 40% among the survivors. Among patients who report pain, 40% report undertreated pain. Strengthening Pain management in cancer is a specific objective of the French Cancer Plan. Providing patient education for cancer pain management is recommended since small to moderate efficacy of patient education on pain intensity and interference was found in all meta-analysis. An effect size comparable with some analgesic agents. However, recommendations suggest improvement in order to increase effectiveness and population reach of those interventions. The DECLIC EPRI intervention aim at addressing all the issues raised by patient education for cancer pain management. It was developed according to the framework of Michie's Behavior change wheel theory.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  1. Patient aged over 18.

  2. Followed in the participant comprehensive cancer center.

  3. All cancer types, location and stage.

  4. Patient under any anticancer treatment (including hormonal therapy) or patient hasstopped his treatment (including hormonal therapy) maximum 2 years before inclusion.

  5. Patient experiencing cancer pain and/or his treatments for 3 months or more.

  6. All previous and concomitant treatments are accepted.

  7. Participation to another clinical trial is accepted.

  8. Patient has accepted to participate to the study and signed informed consent form orhis legal representative.

  9. Patient affiliated to the social security healthcare.

Exclusion

Exclusion Criteria:

  1. Cognitive impairment preventing to understand the patient education program.

  2. Language barrier preventing to understand the patient education program.

  3. Physical impairment preventing patient to attend to the patient education program.

Study Design

Total Participants: 246
Treatment Group(s): 2
Primary Treatment: standrad group
Phase:
Study Start date:
March 05, 2021
Estimated Completion Date:
September 03, 2024

Connect with a study center

  • Institut de Cancérologie de l'Ouest Paul Papin

    Angers, 49000
    France

    Site Not Available

  • AP-HP La Pitié Salpêtrière

    Paris, 75013
    France

    Site Not Available

  • GH Diaconesses Croix Saint Simon (GHDCSS)

    Paris, 75012
    France

    Site Not Available

  • Institut Curie

    Paris, 75005
    France

    Site Not Available

  • Institut Curie

    Saint-cloud, 92210
    France

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.